Rabbit Polyclonal SCARA5 antibody. Suitable for ICC, ELISA, WB, IHC-P and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Synthetic Peptide within Human SCARA5.
View Alternative Names
UNQ2938/PRO28700, SCARA5, Scavenger receptor class A member 5, Scavenger receptor hlg
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SCARA5 antibody (AB118894)
ab118894t 5µg/ml, staining SCARA5 in Formalin-fixed, Paraffin-embedded Human Small intestine tissue by Immunohistochemistry.
- WB
Unknown
Western blot - Anti-SCARA5 antibody (AB118894)
All lanes:
Western blot - Anti-SCARA5 antibody (ab118894) at 1 µg/mL
All lanes:
Human liver tissue lysate
Predicted band size: 53 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SCARA5 plays a role in iron homeostasis as it modulates the cellular uptake of lipocalin-2 and its associated ferric-siderophore complexes. SCARA5 does not work alone; it operates as part of a complex involving ligands such as lipocalin-2 which can influence iron levels in cells and tissues. This interaction is necessary for maintaining proper iron balance and supporting cellular functions that rely on iron availability.
Pathways
SCARA5 is involved in the iron metabolism pathway and influences cellular iron uptake. This pathway interacts with other proteins like hepcidin and ferroportin which are essential for maintaining systemic iron balance. These interactions help to regulate iron absorption transport and storage within the body ensuring adequate iron is available for critical processes like red blood cell production and oxygen transport.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
American journal of cancer research 15:426-438 PubMed40084377
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39000462
2024
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostics (Basel, Switzerland) 13: PubMed37443605
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 23:1-13 PubMed35998226
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35008858
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:666589 PubMed34150631
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 18:95 PubMed32660596
2020
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology 419:40-54 PubMed30914192
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 9:27974-27984 PubMed29963255
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:8867 PubMed29891921
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com